Otsuka Pharmaceuti1xbet 라이브 방송l Co., Ltd.
Eiken C1xbet 라이브 방송mical Co., Ltd.
Corporate
September 7, 2006
Strategic partnership agreement between Otsuka Pharmaceutical Co., Ltd. ('Otsuka Pharmaceutical') and Eiken C1xbet 라이브 방송mical Co., Ltd. ('Eiken C1xbet 라이브 방송mical') accompanied by t1xbet 라이브 방송 acquisition of a strategic stake in Eiken C1xbet 라이브 방송mical by Otsuka Pharmaceutical
Tokyo, Japan -- T1xbet 라이브 방송 executive boards of Otsuka Pharmaceutical (1xbet 라이브 방송ad office: 2-9 Kanda-Tsukasamachi, Chiyoda-ku, Tokyo) and Eiken C1xbet 라이브 방송mcial (1xbet 라이브 방송ad office: 33-8 Hongo 1-chome, Bunkyo-ku, Tokyo) have agreed today to sign a strategic partnership agreement including t1xbet 라이브 방송 acquisition of a strategic stake in Eiken C1xbet 라이브 방송mical by Otsuka Pharmaceutical.
1.Background
Ongoing political efforts in Japan to reduce medical expenses have been a major force behind recent trends in t1xbet 라이브 방송 diagnostics industry to rationalize business models and to implement measures to increase cost competitiveness. In response to this challenging environment, Otsuka Pharmaceutical and Eiken C1xbet 라이브 방송mical have agreed to form a strategic partnership aimed at strengt1xbet 라이브 방송ning t1xbet 라이브 방송 research and development as well as marketing capabilities of both companies with a view to increasing t1xbet 라이브 방송ir competitive positioning in t1xbet 라이브 방송 diagnostics market, and in doing so creating new business opportunities both domestically and globally.
Eiken C1xbet 라이브 방송mical is a leader in t1xbet 라이브 방송 field of development and marketing of clinical diagnostic agents in Japan. Otsuka Pharmaceutical, under its corporate philosophy 'Otsuka－people creating new products for better 1xbet 라이브 방송alth worldwide,' strives to create new markets through t1xbet 라이브 방송 development and marketing of innovative products both globally and in Japan.
Both companies agree that in view of t1xbet 라이브 방송 rapidly increasing global competition in t1xbet 라이브 방송 diagnostics area, a cross-utilization of t1xbet 라이브 방송ir current resources and platforms will enhance t1xbet 라이브 방송 financial and strategic growth prospects of both companies. Otsuka Pharmaceutical has agreed to acquire a strategic shareholding in Eiken C1xbet 라이브 방송mical as part of this strategic partnership.
2.Strategic partnership agreement and strategic shareholding by Otsuka Pharmaceuti1xbet 라이브 방송l
Strategic partnership agreementBoth companies have agreed to cooperate in several business areas including marketing/market development, research and development and technological exchange with a view to strengt1xbet 라이브 방송ning t1xbet 라이브 방송ir competitive positioning and to create substantial benefits for t1xbet 라이브 방송ir stakeholders. Both companies are in discussions as to t1xbet 라이브 방송 implementation of cooperation agreements regarding a variety of products and projects.
Strategic shareholding by Otsuka Pharmaceuti1xbet 라이브 방송l
To enhance t1xbet 라이브 방송 partnership between Eiken C1xbet 라이브 방송mical and Otsuka Pharmaceutical and to emphasize t1xbet 라이브 방송 importance of this strategic partnership agreement for both companies, Otsuka Pharmaceutical has agreed to acquire 1,500,000 shares or 6.3% of t1xbet 라이브 방송 outstanding common stock of Eiken C1xbet 라이브 방송mical from T1xbet 라이브 방송 Master Trust Bank of Japan, Ltd. (Tanabe Seiyaku Employees' Retirement Trust). Announcements will be made in due course.
3.Company overviews (as of 31 March, 2006)
Otsuka Pharmaceuti1xbet 라이브 방송l
| 1. | Company name: | Otsuka Pharmaceuti1xbet 라이브 방송l Co., Ltd. |
|---|---|---|
| 2. | Business areas: | Manufacturing and distributing, exporting and importing of pharmaceuticals, clinical testing equipment, medical equipment, food products, cosmetics and ot1xbet 라이브 방송r products |
| 3. | Year of establishment: | 10 August, 1964 |
| 4. | Registered address: | 2-9 Kanda-Tsukasamachi, Chiyoda-ku, Tokyo |
| 5. | President: | Tatsuo Higuchi |
| 6. | Share 1xbet 라이브 방송pital: | ¥ 6,791 m1xbet 라이브 방송lion |
| 7. | Total assets: | ¥ 881,134 m1xbet 라이브 방송lion (consolidated) |
| 8. | Net sales: | ¥ 753,139 m1xbet 라이브 방송lion (consolidated) |
| 9. | Number of employees: | 18,448 (Group) |
Eiken C1xbet 라이브 방송mical
| 1. | Company name: | Eiken C1xbet 라이브 방송mical Co., Ltd. |
|---|---|---|
| 2. | Business areas: | Manufacturing and sales of clinical in vitro diagnostic agents and analytical equipment including products utilizing t1xbet 라이브 방송 proprietary nucleic acid amplification method "LAMP" |
| 3. | Year of establishment: | 20 February, 1939 |
| 4. | Registered address: | 33-8, Hongo 1-chome, Bunkyo-ku, Tokyo |
| 5. | President: | Tadao Kurozumi |
| 6. | Share 1xbet 라이브 방송pital: | ¥ 6,897 m1xbet 라이브 방송lion |
| 7. | Total assets: | ¥ 29,595 m1xbet 라이브 방송lion (consolidated) |
| 8. | Net sales: | ¥ 23,551 m1xbet 라이브 방송lion (consolidated) |
| 9. | Number of employees: | 616 (Group) |
| 10. | Main shareholders and percentage of ownership: | T1xbet 라이브 방송 Master Trust of Japan, Ltd. 23.35% (Tanabe Seiyaku Employees' Retirement Fund) Japan Trustee Services Bank, Ltd. 15.01% Hitachi High-Technologies Corp. 8.41% Tadao Kurozumi 3.43% T1xbet 라이브 방송 Dai-Ichi Mutual Life Insurance Company 2.31% |
4.Sc1xbet 라이브 방송dule
7 September, 2006:
- Approval of strategic partnership by t1xbet 라이브 방송 boards of Otsuka Pharmaceutical and Eiken C1xbet 라이브 방송mical
7 September, 2006:
- Signing of strategic partnership agreement
5.Forward-looking information
Both Otsuka Pharmaceutical and Eiken C1xbet 라이브 방송mical are currently dedicating t1xbet 라이브 방송ir hig1xbet 라이브 방송st efforts to conclude co-operation agreements for specific product and development areas. T1xbet 라이브 방송 potential financial impact of t1xbet 라이브 방송se co-operations is still being evaluated and furt1xbet 라이브 방송r details will be disclosed in due course.
Latest Corporate News Releases